Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Laboratory Economics Issues Research Report on U.S. Anatomic Pathology Market


The U.S. anatomic pathology market is projected to grow by 7-8% per year, driven by increased utilization of molecular oncology tests.

The publisher of Laboratory Economics has just released The U.S. Anatomic Pathology Market: Forecast & Trends 2022-2024. With this special report, you can tap into 150 pages of proprietary market research that reveals critical data and information about key business trends affecting the anatomic pathology market.

The report reveals that the U.S. anatomic pathology market represented an estimated $25.8 billion of revenue in 2022 with a long-term annual growth rate of 7-8%. Growth is being driven almost entirely by increased molecular oncology testing.

The U.S. anatomic pathology market faces unprecedented change, including the introduction of artificial intelligence tools that increase pathologist productivity, greater utilization management by private payers and persistent reimbursement pressure.

“The introduction of new higher-priced molecular oncology tests and next-generation sequencing for tumor mutation profiling should more than offset price and volume pressure on routine pathology tests,” according to Jondavid Klipp, President of Laboratory Economics.

In addition, the introduction of AI software tools that enhance pathologist productivity has the potential to profoundly change the way pathology is practiced within the next 3-5 years.

The greatest challenge comes from third-party payers, which are instituting prior authorization policies and laboratory benefit management programs designed to lower utilization of anatomic pathology services and genetic tests for cancer.

The report includes:

  • More than 150 charts and graphs
  • Pathology market size and growth rates
  • Detailed estimates for market subsets like uropathology, dermatopathology, and gastrointestinal pathology
  • In-depth analysis of the molecular oncology testing market size and growth rates
  • Medicare claims data for 60+ key pathology codes covering surgical pathology, molecular oncology, immunohistochemistry and special stains, tumor marker immunoassays, FISH testing and flow cytometry
  • Cervical cancer testing trends and pricing data
  • In-office histology lab trends
  • Detailed analysis of the emerging digital pathology & AI market
  • Results from Laboratory Economics Anatomic Pathology and Clinical Lab Trends Surveys from 2015 through 2021

Anatomic pathology companies highlighted include:

  • Ambry Genetics
  • Bako Diagnostics
  • Caris Life Sciences
  • CellNetix Pathology & Laboratories
  • Exact Sciences
  • Foundation Medicine
  • Fulgent Genetics/Inform Diagnostics
  • Guardant Health
  • Labcorp
  • Mayo Clinic Laboratories
  • Myriad Genetics
  • NeoGenomics
  • OPKO/BioReference Labs
  • PathAI/Poplar Healthcare
  • PathGroup
  • Quest Diagnostics
  • Sonic Healthcare/Aurora Diagnostics/ProPath Services

The U.S. Anatomic Pathology Market: Forecast & Trends 2022-2024 is published by Laboratory Economics (http://www.laboratoryeconomics.com), an independent market research firm focused exclusively on the business of pathology and laboratory medicine. Report author Jondavid Klipp has been covering key business trends affecting clinical lab testing and anatomic pathology services for more than 25 years.

Contact Information

Contact: Jondavid Klipp, President

Laboratory Economics

195 Kingwood Park

Poughkeepsie, NY 12601

jklipp@laboratoryeconomics.com

Ph: 845-463-0080

http://www.laboratoryeconomics.com

Share article on social media or email:

Silverlon Receives FDA 510k Clearance for Radiation Dermatitis and Cutaneous Radiation Injury


Silverlon® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden.

This historic achievement is the culmination of more than 20 years of effort, thousands of hours of work and significant investment by our government. We are proud to provide an FDA-cleared product for the management of these injuries and further assist with disaster preparedness for our country.

Argentum Medical, a medical device leader and pioneer of silver-plated dressing technology, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Radiation Dermatitis (RD) and Cutaneous Radiation Injury (CRI) through dry desquamation for its Silverlon® Burn and Wound Care products.

Silverlon is the first medical device to be cleared in the U.S. for management of Cutaneous Radiation Injury through dry desquamation.

“This historic achievement is the culmination of more than 20 years of effort, thousands of hours of work and significant investment by our government. We are proud to provide an FDA-cleared product for the management of these injuries and further assist with disaster preparedness for our country,” states Raul Brizuela, CEO of Argentum Medical.

The key to determining the effectiveness of Silverlon for management of radiological injuries was an $11.6 million development contract awarded to Argentum Medical by the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR).

Peter Antinozzi, Ph.D., Argentum Medical’s Project Manager of the BARDA funded project, credits the resolute efforts of the interdisciplinary project team of industry, government, and academic experts for this achievement. “In the past three years, our highly productive private-public partnership between Argentum Medical and BARDA has yielded two critical FDA clearances to support a joint goal of disaster preparedness against chemical and radiological threats. The experimental approaches to support these clearances were innovative and state-of-the art and involved the development of novel methods and models.”

In 2019, Silverlon received the first FDA clearance for mustard-induced vesicant injuries, which established Silverlon as a safe treatment for chemical warfare injuries such as vapor sulfur mustard burns. Now, in 2022, Silverlon has received the first FDA medical device clearance for both radiation dermatitis and cutaneous radiation injuries. This is truly a unique clearance, a dual-role clearance, which has immediate medical treatment benefits to manage radiation dermatitis, a common side-effect of radiation therapy for cancer treatment, and establishes Silverlon as a safe and effective product to manage cutaneous radiation injuries resulting from accidental or intentional radiation incidents.

“Silverlon technology is highly effective relative to other products on the market because of its ability to stretch and conform across a bodily area, resulting in more exposure to and longer duration on a wounded area,” adds Raul Brizuela. “Rather than rely on a wound dressing that needs to be changed every few hours, Silverlon can be used for much longer periods of time, reducing the need for rapid resupply. The clinical trial data (NCT04238728, clinicaltrials.gov) that supports this novel clearance demonstrated the feasibility, patient compliance, and safety of Silverlon use to manage radiation-induced injuries such as radiation dermatitis.”

Silverlon has received FDA clearances for multiple indications since 2003.

Silverlon’s Military Heritage

Developed for combat injuries, Silverlon antimicrobial technology is used throughout the U.S. Military for the management of burn and blast injuries. Silverlon products contain 50 to 100 times more metallic silver ions than silver-impregnated dressings and have been shown to be highly effective in hostile and austere military environments.

Silverlon is incorporated into numerous deployed Medical Tactical Combat Casualty Care kits and is also supplied in bulk to Combat and Support Hospitals and Tactical Forward Surgical Teams. The wound dressing is also included in burn care protocols in the Joint Theater Trauma System Clinical Practice Guideline.

Silverlon burn products and protocols are extensively used by the U.S. Army and by U.S. Air Force Critical Care Air Transport (CCAT) teams and are taught at the U.S. Air Force School of Aerospace Medicine Critical Care Air Transport Basic Course.

Beyond the military, Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds.

Argentum Medical continues to explore new applications and markets for its Silverlon technology in keeping with its corporate mission to improve clinical outcomes. For more about Silverlon, visit http://www.silverlon.com.

The development of Silverlon for use on mustard-induced vesicant injuries, radiation dermatitis and cutaneous radiation injuries has been funded in whole or in part with federal funds from BARDA under contract numbers HHSO100201300019C and HHSO1002018000022C.

About Silverlon

Silverlon® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden. Silverlon was originally developed for the U.S. military, where it is still extensively used for management of burn and blast injuries. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds. For more information, visit http://www.silverlon.com

About Argentum Medical

Argentum Medical pioneered the use of silver-plated nylon. Specializing in the development of innovative products made from silver-plated nylon, the company continues to explore new applications and markets for its Silverlon® technology in keeping with its corporate mission to improve clinical outcomes.

###

Share article on social media or email:

Hammes Healthcare celebrates opening of The MetroHealth Glick Center in Cleveland


It has been an honor to work with Walter Jones, Dr. Boutros, and the entire MetroHealth community over the past five years on this truly transformational project.

Hammes Healthcare, a leading provider of consulting and project management services, is proud to celebrate the opening of the new MetroHealth Glick Center in Cleveland, Ohio.

The new 386-bed, 11-story Glick Center is part of a wider campus transformation program focused on healthcare equity for the community. The Glick Center replaces MetroHealth’s aging main hospital and serves as the focal point for a redeveloped and revitalized 52-acre campus in Cleveland’s West 25th Street neighborhood. The new campus includes 25 acres of green space and will be the first hospital-led EcoDistrict in the world.

Hammes was first engaged by MetroHealth in November 2017 shortly after plans for the Campus Transformation were announced. From the onset, Hammes worked with MetroHealth, the City of Cleveland Planning Commission, and other local authorities to advance the program. Throughout the design and construction phase, Hammes collaborated with project partners, including HGA, Moody Nolan, and Signet Real Estate Group, to keep the project on schedule and on budget. Hammes’ value engineering efforts provided for significant additional resources that were leveraged to enhance the program’s healthcare services and overall vision.

“As the owner’s representative for our Campus Transformation Program, the Hammes team demonstrated a true commitment to MetroHealth focused on collaboration and resource management to ensure schedule compliance and consistent budget control practices,” said Walter Jones, MetroHealth Senior Vice President, Campus Transformation. “Their focus and execution on value engineering and best practice management provided opportunities for MetroHealth to incorporate improvements to the project.”

“It has been an honor to work with Walter Jones, Dr. Boutros, and the entire MetroHealth community over the past five years on this truly transformational project,” said Nancy Connolly, President of Hammes Healthcare. “This project has already had an important economic impact on Cleveland and will bring quality, accessible healthcare to the residents Cuyahoga County for decades to come.”

About Hammes Healthcare

Hammes Healthcare is a national consulting firm that provides real estate and market strategy, facility planning, project management and development services to the healthcare industry. As a reflection of its commitment to the healthcare industry, Hammes has been recognized as one of the nation’s leading healthcare developers by Modern Healthcare’s Construction & Design Survey for 24 consecutive years—including 19 years as No. 1—and by Revista’s Outpatient Healthcare Real Estate Development Report. Hammes has managed in excess of 57 million square feet of complex new, expansion, renovation, replacement, ambulatory care, and acute care projects with a value of more than $23 billion for hospitals and health systems nationwide. Headquartered in Milwaukee, Wisconsin, Hammes provides services through a network of regional offices strategically located across the United States. https://www.hammes.com/

Share article on social media or email:

RevSpring Deviceless Payments Now Integrated with Epic Credit Card Framework


“Deviceless Payments provide a reliable interim payment solution when supply chain issues make it difficult to source payment devices,” Williams added.

RevSpring, the leading provider of healthcare engagement and payment solutions, is pleased to announce that its Deviceless Payments solution is now available within the Epic Credit Card Framework. PCI compliance and fraud are risk factors when healthcare staff receives credit card and ACH information over the phone. Deviceless Payments provide a safe and secure way for staff to take patients’ credit card and ACH payments using the patient’s own device.

Integrated seamlessly within the open credit card framework, Deviceless Payments can be initiated via text, email or phone, mitigating PCI compliance risk by bypassing direct staff interaction with the patient when processing card information. This protects the patients’ privacy while conveniently and expeditiously fulfilling a payment obligation.

Providers who leverage Epic’s Credit Card Framework within Hyperspace—where RevSpring serves as the merchant and gateway—benefit from a frictionless payment environment. The integration ensures all native Epic functionality and workflows work as intended, while improving payment rates by giving patients another method to make payments quickly and securely.

“Our Deviceless Payments solution is a valuable addition to the long and growing list of successful RevSpring product integrations with Epic. We are pleased to now facilitate frictionless payments in Epic Hyperspace, which boost PCI compliance while increasing staff productivity,” said Casey Williams, senior vice president, engagement and payment applications, at RevSpring.

“Supporting our customers’ financial goals is a key objective for RevSpring. Deviceless Payments provide a reliable interim payment solution when supply chain issues make it difficult to source payment devices. In addition to increasing payments, customers can look forward to reduced equipment costs since P2PE devices are no longer required with Deviceless Payments,” Williams added.

Today, more than 200 Epic clients representing 1000 locations derive extended value from their patient financial engagement and payment solutions with precisely integrated end-to-end solutions from RevSpring. RevSpring has announced eight applications available in the Epic App Market:

About RevSpring

RevSpring leads the market in engagement and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful suite of patient engagement, OmniChannel communications and payment solutions backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from preservice to post-service, RevSpring improves the patient experience and outcomes for providers and their patients. To learn more, visit revspringinc.com/healthcare.

Epic, Willow, MyChart, and App Orchard are trademarks or registered trademarks of Epic Systems Corporation.

Share article on social media or email:

First California Lab to offer All-in-One RSV, COVID-19, Influenza A/B Test for Schools, Individuals, and Businesses


My Care Labs lab technician Edgar Perez working with combo PCR samples in the laboratory.

My Care Labs lab technician Edgar Perez working with combo PCR samples in the laboratory.

“We expect hospitalizations to be up this winter for both RSV and Influenza, along with Covid-19. Masks off and more congregating leads to more community spread,” said Harvey Singh, My Care Labs CEO.

My Care Labs, a California infectious disease testing laboratory, announces availability of all-in-one RSV, COVID-19, and Influenza A/B test kits for schools, individuals, and businesses. Our new combo test diagnoses individuals for four diseases in one easy, accurate test. Unfortunately, RSV hospitalizations are ramping up among children and elderly alongside Covid-19 and Flu, with a surge of cases seen weeks earlier than the normal winter season.

At My Care Labs, we’re suited up for the latest virus: Respiratory Syncytial Virus, or RSV. With symptoms similar to the cold or flu, it’s an ortho-pneumo-virus causing issues as serious as bronchiolitis and pneumonia in people from infancy to old age. “We expect hospitalizations to be up this winter for both RSV and Influenza, along with Covid-19. Masks off and more congregating leads to more community spread,” said Harvey Singh, My Care Labs CEO.

My Care Labs is launching a 4-panel combo test this month for RSV, all Covid-19 variants, and Influenza A and B. One fast, easy, and secure test. Organizations can use in-person testing or utilize our self-test option with pre-paid FedEx priority overnight envelopes for fast 24-48 hour turnaround. Contact us today for help setting up your bulk test kit orders or in-person testing program for all four diseases.


  • No cost to students, teachers, staff, and vendors, with any insurance plan
  • Negotiated low rate for uninsured individuals
  • 24-hour PCR results for early detection
  • One-time simple registration*

We offer free bulk test kits and $0 testing services – both with 24-hour results. Our laboratory is prepared to test school districts of any size.

Click here to learn more and to book a discovery call for your school district.

My Care Labs is a CLIA-certified COVID-19 RT-PCR testing facility with its own laboratory and pop-up locations throughout California with same-day and 24-hour turnaround times. The company also offers managed in-person testing by trained My Care Labs medical staff as well as self-service next-day testing. All services are provided at no-cost with any insurance plan including: Aetna, Anthem Blue Cross/Blue Shield, Healthnet, Kaiser, Medi-Cal, MediCare, and most others. Through its business operations in Silicon Valley, Riverside County, Coachella Valley, India, and Brazil, My Care Labs is partnering and collaborating with leading biopharma companies, institutions, and governments to support personalized healthcare across California. Further information is available on the company’s website, http://www.mycarelabs.com. Stay in touch on LinkedIn or @mycarelabs on Twitter. Reach out to us at media@mycarelabs.com.

Share article on social media or email:



Memorial Hospital Pembroke achieves reaccreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program®


Memorial Hospital Pembroke

“We are honored that our bariatric center has been reaccredited because it gives patients peace of mind that their care is being managed with the highest standards of surgical care for weight-loss and other metabolic issues,” said Stephen Demers, CEO, Memorial Hospital Pembroke.

When it comes to patients seeking surgical treatment for weight-loss and other metabolic conditions, healthcare experts recommend finding a nationally accredited bariatric center that meets the highest standards for patient safety and quality. South Florida patients don’t need to go far as Memorial Hospital Pembroke recently received reaccreditation for this service by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP®), a joint Quality Program of the American College of Surgeons (ACS) and the American Society for Metabolic and Bariatric Surgery (ASMBS).

Alongside Memorial Hospital Pembroke, there are two other bariatric centers part of Memorial Healthcare System that also hold this accreditation – one at Memorial Regional Hospital in Hollywood and another at Memorial Hospital West in Pembroke Pines – all three bariatric centers raising the standards of care high for the benefit of patients.

“We are honored that our bariatric center has been reaccredited because it gives patients peace of mind that their care is being managed with the highest standards of surgical care for weight-loss and other metabolic issues,” said Stephen Demers, CEO, Memorial Hospital Pembroke.

The MBSAQIP Standards, Optimal Resources for Metabolic and Bariatric Surgery, ensure that metabolic and bariatric patients receive multidisciplinary medical care, which improves patient outcomes and long-term success. MBSAQIP-Accredited centers offer preoperative and postoperative care designed specifically for patients with obesity.

Memorial Hospital Pembroke’s reaccreditation comes with a commitment to quality care that begins with expertly trained staff and the leadership of an experienced bariatric surgeon, who is Dr. Brett Cohen, Chief, Adult General Surgery and Bariatric Surgery Program. The rest of the bariatric surgical team include Dr. Jeremy Gallego Eckstein, Associate Medical Director, Bariatric Surgery; Dr. Joseph Melendez-Davidson, general and bariatric surgeon; Dr. Emil Matei, board certified general surgeon and medical director, Bariatric Program, Memorial Hospital West. The program at Memorial Hospital Pembroke and the other facilities is tasked with continuous review of surgical data as they continue improving the structure and outcomes expertise necessary to provide safe, efficacious, and high-quality care to all metabolic and bariatric patients.

To earn MBSAQIP Accreditation, Memorial Hospital Pembroke met essential criteria for staffing, training, facility infrastructure, and patient care pathways, ensuring its ability to support patients with obesity. The center also participates in a national data registry that yields semiannual reports on the quality of its surgical outcomes and identifying opportunities for quality improvement. The MBSAQIP Standards, Optimal Resources for Metabolic and Bariatric Surgery, are published by the ACS and the ASMBS.

After applying for MBSAQIP Accreditation, centers undergo an extensive site visit by an experienced bariatric surgeon who reviews the center’s structure, processes, and clinical outcomes data. Centers that earn accreditation are awarded a specific designation level, depending on how many patients it serves annually, critical care capabilities, the types of procedures provided, and whether it provides care to patients under the age of 18.

The Centers for Disease Control and Prevention (CDC) estimates about 93 million adults in the United States are affected by obesity and that number continues to increase. The disease of obesity increases the risks of morbidity and mortality because of the diseases and conditions that are commonly associated with it, such as type II diabetes, hypertension, cardiovascular disease, and cancer, among other health risks. Metabolic and bariatric surgery has proven to be effective in the reduction of comorbid conditions related to obesity.* Working together, the ACS and the ASMBS have developed accreditation standards for metabolic and bariatric surgery to assist patients with obesity in identifying centers that provide optimal patient care.

*Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery: A Systematic Review and Meta-analysis. JAMA. 2004;292(14):1724-1737. DOI:10.1001/jama.292.14.1724.

About Memorial Healthcare System

Memorial Healthcare System is one of the largest public healthcare systems (by revenue) in the U.S. and a national leader in quality care and patient satisfaction. Recently named the #1 healthcare brand in the U.S. (Monigle’s “Humanizing Brand Experience”), it features a patient and family-centered approach to care at facilities that include Memorial Regional Hospital, Memorial Regional Hospital South, Joe DiMaggio Children’s Hospital, Joe DiMaggio Children’s Health Specialty Center in Wellington, Memorial Hospital West, Memorial Hospital Pembroke, Memorial Hospital Miramar, and Memorial Manor nursing home. To learn more, visit mhs.net.

About the American College of Surgeons

The American College of Surgeons (ACS) is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical education and practice and to improve the quality of care for surgical patients. Its achievements have placed it at the forefront of American surgery and have made the College an important advocate for all surgical patients. The College has more than 82,000 members and is the largest organization of surgeons in the world.

About the American Society for Metabolic and Bariatric Surgery

The American Society for Metabolic and Bariatric Surgery (ASMBS) is the largest organization for metabolic and bariatric surgeons in the world, with more than 4,200 members. It is a not-for-profit organization that works to advance the science of metabolic and bariatric surgery. The ASMBS is committed to educating medical professionals and the lay public about metabolic and bariatric surgery, including the associated risks and benefits, as a treatment option for obesity.

Share article on social media or email:

Rosy, The First and Only Physician-Helmed App for Sexual Wellness, is Now Available in Canada


“Sexual wellbeing is an integral part of overall health –– Rosy provides research-backed tools that empower women (and their doctors) to thrive in all aspects of their lives.” – Dr. Lyndsey Harper

Rosy, a Webby Award winning app that addresses sexual health concerns for women throughout their lifespans, is now available throughout Canada. To celebrate the Canadian launch, users can use the code WELCOMECA for a free month of the Silver Membership.

Led by Lyndsey Harper, MD (Rosy’s CEO and Founder), Rosy is a first-of-its-kind app that offers personalized solutions for sexual wellness. When signing up, each user takes a comprehensive Sexual Wellness Quiz, allowing Rosy to personalize a program based on their unique needs and priorities. Next, they’ll receive an evidence-based, guided path to optimal sexual wellbeing that can be completed at their own pace. The Rosy team partnered with psychologists to fold elements of cognitive-behavioral therapy (CBT) into the program, including practices like thought reframing and modeling that help women to approach sexual wellness in a more positive way.

“With a guiding mission to make sexual wellness tools accessible to as many women as possible, we’re thrilled to be launching Rosy in Canada,” said Lyndsey Harper, MD, Founder and CEO of Rosy. “Sexual wellbeing is an integral part of overall health –– Rosy provides research-backed tools that empower women (and their doctors) to thrive in all aspects of their lives.”

Additional subscriber tools include individual and group sex coaching, audio and written erotica, educational videos, supportive online community, and much more. Rosy also has a robust collection of free materials, including educational videos, blog posts, and more.

Rosy was created to be a safe place for women to find connection and interventions for sexual health needs on their own terms, all within one trusted, research-backed platform. And medical professionals agree – more than 7% of Ob/Gyns in the United States are now recommending Rosy to their patients.

Providers interested in recommending Rosy to their female patients are welcome to email professionals@meetrosy.com for additional information.

For media inquiries, please contact rosy@rachelvandolsen.com

About Rosy:

Founded in 2019 by Dr. Lyndsey Harper in collaboration with a team of doctors and psychologists, Rosy was born out of a genuine need. While practicing as an Ob/Gyn, Dr. Harper came across myriad patients with sexual health questions and concerns that had often gone unaddressed for many years. As part of her ISSWSH fellowship in sexual wellness, she discovered real evidence-based solutions for women who face sexual challenges – however, they’re often ignored due to embarrassment and lack of proper physician time and training. Rosy was created to be a safe place for women to find connection and interventions for sexual health needs on their own terms, all within one trusted, research-backed platform. And medical professionals agree – more than 7% of Ob/Gyns in the United States are now recommending Rosy to their patients.

Website: https://meetrosy.com/

Instagram: @meet_rosy

The Rosy App: https://meetrosy.app.link/h1yxnl3eknb

Share article on social media or email:



MD Logic Health Announces New Partnership with Cynthia Thurlow


“I chose to work with MD Logic because of my professional insights and personal experience regarding their ethical, clean, and complete label transparency” stated Cynthia Thurlow.

MD Logic Health (“MD Logic”), a leading provider of professional-grade nutraceuticals and physician-recommended dietary supplements made in the USA, announced a major partnership with Cynthia Thurlow.

This collaboration was possible because of our mutual philosophy to create supplements made from the purest, ethically, and sustainably sourced raw materials to create potent and effective nutraceuticals.

“I chose to work with MD Logic because of my professional insights and personal experience regarding their ethical, clean, and complete label transparency. MD Logic’s strict standards and double laboratory analysis of each ingredient are unparalleled. Manufacturing is done in a USA GMP-certified facility that is precise about the Purity, Potency, Identity, and Strength of every ingredient,” stated Cynthia Thurlow.

The first product under this collaboration is Creatine Monohydrate by Cynthia Thurlow, powered by MD Logic Health. Creatine is a naturally occurring organic compound composed of three amino acids: arginine, glycine, and methionine.

We selected Creatine Monohydrate because of the substantial evidence and clinical data supporting muscle and brain function. In addition, both are shown to be leading predictors of health span and longevity.

Creatine has been shown to support muscle strength, endurance, and growth in men, women, and people over fifty. Emerging and ongoing research has demonstrated the power of Creatine Monohydrate. Research has also shown that Creatine Monohydrate supports the brain’s energy requirements and supports focus, memory, and intense brain activity.

MD Logic Cofounder Scott Emmens added, “Our partnership with Cynthia is aligned directly with MD Logic’s mission and philosophy. As a former bodybuilder and current fitness and wellness advocate, I have personally taken Creatine Monohydrate on and off for twenty years. During the research with Cynthia, it became clear that I need Creatine now more than ever as I enter my fifties. The research was robust and striking regarding the support for both muscle strength and cognitive support. I know that lean muscle mass is one of the most important indicators of health and life span; adding 3 grams of creatine per day in my daily diet is a no-brainer.”

We expect to launch this product by the third week of November 2022. We will be offering pre-launch incentive pricing starting next week. Please visit us at http://www.mdlogichealth.com for more information.

About Cynthia Thurlow

Cynthia Thurlow, NP, intermittent fasting and nutrition expert, author, and a two-time TEDx speaker. Cynthia is passionate about helping people find wellness through the healing power of nutrition and fasting. Cynthia hosts the Everyday Day Wellness Podcast and is Co-Host of the Intermittent Fasting Podcast. In addition, she has interviewed hundreds of top experts from around the world. Cynthia believes it is possible to feel better tomorrow than you do today and wants to equip you to experience that freedom!

“Wellness starts from within. I firmly believe that you can live a healthier life today through lifestyle choices and dietary changes than you did yesterday. The healing journey begins one step at a time.”

To learn more about Cynthia Thurlow, please, visit her at https://cynthiathurlow.com/my-story/

To listen to her Everyday Wellness Podcast, click on this link https://podcasts.apple.com/us/podcast/everyday-wellness/id1435214303

To listen to her Intermittent Fasting Podcast, click on this link https://podcasts.apple.com/us/podcast/the-intermittent-fasting-podcast/id1228755008

About MD Logic Health

MD Logic Health – Supplementing Life since 2005. At MD Logic Health, we promise to supplement your daily nutrition to help you live your best life. Our Company was created and founded by passionate health and wellness advocates. Our quality is at the core of who we are and what we offer. Our purity and efficacy come from the superior ingredients used in every MD Logic Health product. Individual dietary and non-dietary ingredients are tested for identity, strength, purity, and composition compliance to ensure maximum effectiveness before use. We believe our customers deserve the highest quality. To learn more about us, please visit us at https://www.mdlogichealth.com.

Follow MD Logic Health

https://www.facebook.com/mdlogichealth

https://www.instagram.com/mdlogichealth

https://www.twitter.com/mdlogichealth

https://www.tiktok.com/@mdlogichealth

https://www.linkedin.com/company/md-logic

MD LOGIC HEALTH CONTACT:

Jyoti Hardat

jhardat@mdlogichealth.com

Phone (877) 629-8711 x700

Share article on social media or email:



MOLLI Surgical’s Breast Cancer Technology Named in TIME’s 2022 Best Inventions


News Image

MOLLI Surgical’s wire-free and radiation-free breast cancer localization technology has been named to TIME’s 2022 Best Inventions list in the Medical Care category. Every year, TIME recognizes inventions that are solving compelling problems in creative ways.

When patients learn they have cancer, they face a difficult road ahead. If the patient needs surgery, MOLLI® is the smallest localization device on the market that marks the lesion for the surgeon to remove it precisely and confidently. Marking the lesion has traditionally been a difficult experience for the patient — MOLLI can help make this experience less traumatic.

MOLLI Surgical started after one patient stepped up and shared her journey using the traditional wire localization method — specifically, the anxiety, pain, and discomfort she experienced while waiting for surgery. Listening to her inspired both the device and the company. Since then, the team has been on a mission to drastically improve the overall experience for patients and care teams.

MOLLI is FDA-cleared and Health Canada-approved. It allows surgeons to pinpoint cancerous tissue faster and with confidence, offering an improved experience and better cosmetic outcomes for breast cancer patients. MOLLI can also be used to improve the lives of patients with other types of cancers. The wire-free technology includes the MOLLI Marker®, about the size of a sesame seed, which is reliably detected using the MOLLI Wand®. The MOLLI Tablet® then displays the distance down to the millimeter between the tip of the MOLLI Wand and the MOLLI Marker.

“Our team toils over every design choice to reduce the mental, physical and systemic burden on physicians and care teams while truly keeping the patient at the center of everything we do,” said Ananth Ravi, Ph.D., President and CEO of MOLLI Surgical Inc. “Words can’t convey how thrilled we are that TIME has recognized what we’ve achieved with MOLLI. This honor will continue to motivate us to improve the healthcare experience while making MOLLI available to as many people as possible.”

To learn more, please visit mollisurgical.com.

About MOLLI Surgical:

MOLLI Surgical started in the operating room, where surgeons were using dated tools to treat cancer patients — and we knew we could do better. Our surgical wand is precise, reliable, easy-to-use, and built with the realities of the operating room in mind. More importantly, it is built with patients in mind. Our technology replaces procedures to mark lesions with one that is more precise, efficient, and cost-effective. MOLLI Surgical is proud to build the advanced equipment that patients prefer to have and that physicians prefer to use. Follow us on Facebook, LinkedIn, Twitter, and YouTube.

Share article on social media or email: